Bharat Biotech's Coronavirus Vaccine Gets a Nod from Indian Regulator

Bharat Biotech's Coronavirus Vaccine Gets a Nod from Indian Regulator

Assessment

Interactive Video

Business, Engineering, Health Sciences, Life Skills, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

The transcript discusses the development and clinical trials of an inactivated vaccine, highlighting its traditional approach and the use of a TLR 7 agonist. It covers the vaccine's efficacy, data collection, and potential to address new variants. The logistical challenges and government response in India are examined, along with ethical and financial considerations. The speaker emphasizes community support over profit and mentions international collaborations and future plans, including a nasal drop strategy. The potential for future pandemics is acknowledged.

Read more

3 questions

Show all answers

1.

OPEN ENDED QUESTION

3 mins • 1 pt

What is the significance of the immunogenicity data mentioned in the text?

Evaluate responses using AI:

OFF

2.

OPEN ENDED QUESTION

3 mins • 1 pt

What challenges does the government face in immunizing a large population?

Evaluate responses using AI:

OFF

3.

OPEN ENDED QUESTION

3 mins • 1 pt

What are the potential future pandemics mentioned by the speaker?

Evaluate responses using AI:

OFF